Live Music for Critically Ill Children
Effect of a Personalized Music Intervention on Stress Reduction in the Paediatric Intensive Care Unit: a Pilot Study
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Rationale: Admission into a pediatric intensive care unit (PICU) can be a highly stressful experience, with many children demonstrating posttraumatic stress symptoms. Most patients require titration of pain and sedation medications to facilitate care, but there is increasing concern of the impact of these medications on the developing brain and increased health risks, including drug withdrawal syndrome, delirium, and impaired circadian rhythm. One potential nonpharmacologic approach to decreasing stress and improving comfort is live-performed music therapy. Among mechanically ventilated adults, music therapy decreased physiologic and psychologic responses to stress (e.g., vital signs, self-reported anxiety) and sedative use. The use of live-performed music may be more advantageous than recorded music with a critically ill population because a music therapist is trained to manipulate musical elements to facilitate the desired outcomes and can respond immediately and adequately in response to the patient's reactions. Objective: To study the effects of live-music therapy on patient comfort, and on patient and parental stress levels and parent-child interaction, use of sedato-analgesic drugs, on haemodynamics and respiration and on the occurrence of patient-ventilator synchrony. Study design: Randomised, non-blinded pilot study Study population: Children \< 5 years old and with expected mechanical ventilatory support for at least 48 hours after inclusion. Intervention: Live-music or care-as-usual. Main study parameters/endpoints: The main study endpoint is patient comfort measured with the Dutch Version of the COMFORT Behaviour (COMFORT-B) scale. Secondary endpoints include parental stress levels, changes in hemodynamic variables (heart rate, blood pressure), changes in respiratory parameters (respiration rate, oxygen saturation, pressure-rate product, pressure-time product), daily cumulative dose of benzodiazepines, alpha-2-agonists and opioids, on-demand boluses of benzodiazepines and opioids, number of asynchronous breaths, and DNA methylation of stress genes,
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedFebruary 25, 2025
February 1, 2025
12 months
February 4, 2025
February 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The main study endpoint is patient comfort measured with the Dutch Version of the COMFORT Behavior (COMFORT-B) scale
The Comfort B score is used to assess patient comfort. The Comfort-B scale used in this study is a behavioral clinical scale that consists of six factors: alertness, calmness/agitation, respiratory response (or crying, used in patients with no mechanical ventilation), physical movement, muscle tone, and facial tension.(9) Each factor can be scored with values ranging between 1 and 5, generating scores between 6 and 30 points.
Daily until PICU discharge or up to 28 days, whichever may come first
Secondary Outcomes (12)
Parental stress levels
Within the first 24 hours of PICU admission, and at PICU discharge or at 28 days whichever may come first
Quantification of the degree of DNA methylation of stress-related genes.
Within the first 24 hours of PICU admission, and at PICU discharge or at 28 days whichever may come first
Cumulative dose of benzodiazepines, alpha-2-agonists and opioids
Daily until PICU discharge or up to 28 days, whichever may come first
Percentage of asynchronous breaths
Daily until PICU discharge or up to 28 days, whichever may come first
Heart rate
Daily until PICU discharge or up to 28 days, whichever may come first
- +7 more secondary outcomes
Study Arms (2)
Live-music therapy
EXPERIMENTALCare as usual
NO INTERVENTIONInterventions
Children will be offered live-music therapy for 3 consecutive sessions, 30 minute sessions in which 10 to 20 minutes of music is provided by a trained music therapist in the presence of parents. In the sessions, the music therapist will make a tailored plan for each child to avoid overstimulation, which includes choosing the appropriate instrument, determining the child's behavioural state, and continuously monitoring the child (i.e., looking for signs of relaxation but also of overstimulation such as tension, crying movements, hiccups, yawning or frowning). The music therapist will collaborate with parents in constructing a program for the sessions. Parents will be actively involved in the sessions, to stimulate their role as caregiver and empower them. The contents of the live-music is thus constantly evaluated and adapted for the individual child.
Eligibility Criteria
You may qualify if:
- Children \< 5 years old a
You may not qualify if:
- CNeurocognitive disorder,
- Admitted post-operatively with an expected length of stay \<48 hours,
- Critical situation where end-of-life care is expected
- Being deaf or suffer from any other hearing impairment, which would not allow for the Music Intervention to be administered
- Parents are unable to understand / speak Dutch
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.dr.
Study Record Dates
First Submitted
February 4, 2025
First Posted
February 25, 2025
Study Start
April 1, 2025
Primary Completion
March 31, 2026
Study Completion
April 30, 2026
Last Updated
February 25, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share